MGMT and central nervous system cancer: Since gliomas show distinct molecular hallmarks, we next performed an integrated analysis of PD-L1 TPS and molecular genetic status: IDH mutation, TERT promoter mutation, MGMT promoter methylation and loss of heterozygosity of 1p and 19q (LOH 1p/19q).